Senior Clinical Lecturer in Paediatric Oncology/Honorary Consultant in Paediatric Oncology
Dr Gatz looks after children diagnosed with solid tumours. She can be found on the ward or in the outpatients clinic.
Dr Gatz is an investigator on early Phase clinical trials testing new therapies for the treatment of children with solid cancers. Her key research areas are early Phase trials and drug development for children with cancer, paediatric sarcomas and DNA repair/ role for DNA repair inhibitors in paediatric cancers. Her interest and expertise reaches from preclinical laboratory-based studies through to early Phase trials.
She is a member of Innovative Therapies for Children with Cancer (ITCC), of the NCRI sarcoma Clinical Studies Group including its Young Onset Soft tissue Sarcoma (YOSS) subgroup and translational lead of the European paediatric Soft tissue Sarcoma Study Group (EpSSG) Phase I/II committee.
To find out more about Dr Gatz’s research see her University of Birmingham profile [opens in new window].
0121 333 8234
- Paediatric sarcoma, especially soft tissue sarcoma
- Research into DNA repair and DNA damage signalling in paediatric cancer
- Novel therapies for children with solid cancers